The coalition includes partners from all over the world, including universities, research centers, and health systems in South Asia, Africa, South America, and the US.
Qiagen has benefited from unexpected tailwinds due to COVID-19 testing and envisions post-pandemic growth with recently acquired NeuMoDx as a key contributor.